TW200304809A - Composition for treating osteoarthritis - Google Patents

Composition for treating osteoarthritis Download PDF

Info

Publication number
TW200304809A
TW200304809A TW092106719A TW92106719A TW200304809A TW 200304809 A TW200304809 A TW 200304809A TW 092106719 A TW092106719 A TW 092106719A TW 92106719 A TW92106719 A TW 92106719A TW 200304809 A TW200304809 A TW 200304809A
Authority
TW
Taiwan
Prior art keywords
compound
solution
mmol
arthritis
ethyl acetate
Prior art date
Application number
TW092106719A
Other languages
English (en)
Chinese (zh)
Inventor
Takefumi Gemba
Fumihiko Watanabe
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of TW200304809A publication Critical patent/TW200304809A/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/061,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/29Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/64Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton
    • C07C323/67Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton containing sulfur atoms of sulfonamide groups, bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/26Radicals substituted by sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/34Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW092106719A 2002-03-27 2003-03-26 Composition for treating osteoarthritis TW200304809A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002087318 2002-03-27

Publications (1)

Publication Number Publication Date
TW200304809A true TW200304809A (en) 2003-10-16

Family

ID=28449368

Family Applications (1)

Application Number Title Priority Date Filing Date
TW092106719A TW200304809A (en) 2002-03-27 2003-03-26 Composition for treating osteoarthritis

Country Status (4)

Country Link
JP (1) JPWO2003080041A1 (ja)
AU (1) AU2003221158A1 (ja)
TW (1) TW200304809A (ja)
WO (1) WO2003080041A1 (ja)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11246527A (ja) * 1998-03-02 1999-09-14 Shionogi & Co Ltd Mmp−8阻害剤
JP2000143650A (ja) * 1998-11-13 2000-05-26 Takeda Chem Ind Ltd 新規チアゾリジン誘導体、その製造法および用途
US6458822B2 (en) * 2000-03-13 2002-10-01 Pfizer Inc. 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
JP2001335575A (ja) * 2000-03-21 2001-12-04 Ishihara Sangyo Kaisha Ltd ニトロエテンアミン誘導体またはその塩、ならびにそれらを含有する医薬組成物
WO2001083464A1 (fr) * 2000-04-21 2001-11-08 Shionogi & Co., Ltd. Derives d'oxadiazole efficaces en matiere de traitement ou de prevention d'etats pathologiques glomerulaire
US6949566B2 (en) * 2000-09-29 2005-09-27 Shionogi & Co. Ltd. Thiazole and oxazole derivatives

Also Published As

Publication number Publication date
AU2003221158A1 (en) 2003-10-08
WO2003080041A1 (fr) 2003-10-02
JPWO2003080041A1 (ja) 2005-07-21

Similar Documents

Publication Publication Date Title
US11045476B2 (en) Compounds and methods for inducing chondrogenesis
ES2295128T3 (es) Derivados de bencimidazol como inhibidores de quimasa humana.
JP3621427B2 (ja) 糸球体障害治療または予防剤
KR101046039B1 (ko) 프로판-1,3-디온 유도체 또는 그의 염
JPH0368859B2 (ja)
TW200803852A (en) Inhibitors of histone deacetylase for the treatment of disease
WO1998011111A1 (fr) Composes de thienotriazolodiazepine et leurs utilisations a des fins medicinales
WO2003080042A1 (fr) Inhibiteur de decomposition pour matrice extracellulaire de cartilage
TW202400584A (zh) 基質金屬蛋白酶(mmp)抑制劑及其使用方法
CA2389032C (en) Preventive or therapeutic agents for inflammatory diseases of intestine
JP2002529447A (ja) N−アリールスルホニルアミノ酸オメガ−アミド
WO1992018488A1 (fr) Nouveau derive d'oxazinone
US20060135488A1 (en) PTP1b inhibitors
WO2001083464A1 (fr) Derives d'oxadiazole efficaces en matiere de traitement ou de prevention d'etats pathologiques glomerulaire
JPH0848671A (ja) ベンズイミダゾール誘導体
TW200304809A (en) Composition for treating osteoarthritis
JPH0920755A (ja) 両性型三環系化合物
EP1270569A1 (en) Substituted tryptophan derivatives
TW455588B (en) Angiogenesis inhibiting thiadiazolyl pyridazine derivatives
CA2856100A1 (en) Nitrogen-containing fused ring compounds as crth2 antagonists
JP4575167B2 (ja) 置換ベンゾジオキセピン
PL125527B1 (en) Process for preparing n-/1-methyl-2-pyrrolidylmethyl/-2,3-dimethoxy-5-methylsulfamylbenzamide
WO2022022372A1 (zh) 硫代苯并吡喃类化合物及其在制备治疗类风湿性关节炎药物中的应用
WO2022022373A1 (zh) 苯并吡喃衍生物及其在制备治疗类风湿性关节炎的药物中的应用
RU2704967C1 (ru) Карбоксамидные производные изоксазолина, способ их получения и применения для лечения воспалительных заболеваний